Read + Share
Amedeo Smart
Independent Medical Education
Holz FG, Iida T, Maruko I, Sadda SR, et al. A CONSENSUS ON RISK MITIGATION FOR BROLUCIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Patient Selection, Evaluation, and Treatment. Retina 2022;42:1629-1637.PMID: 35994582
Email
LinkedIn
Facebook
Twitter
Privacy Policy